Brief: Q2 Operating Result Turns To Profit Of SEK 4.9 Million
Aug 21 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q2 NET SALES 19,3 (0) MSEK
* Q2 OPERATING PROFIT SEK 4.9 MILLION VERSUS LOSS SEK 9.7
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr1FFwn9
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln